Stelara (ustekinumab ... But thanks to advances in PsA treatments, most disease complications can be avoided. Juvenile psoriatic arthritis is a type of juvenile idiopathic arthritis.

While you wait for the groundhog to make his determination this weekend, take some time to buff up your knowledge of rheumatoid arthritis, a chronic autoimmune disease that affects about 1.5 million ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Celltrion’s Steqeyma, a biosimilar that references Johnson & Johnson’s blockbuster monoclonal antibody Stelara ... can treat plaque psoriasis, psoriatic arthritis, Crohn’s disease and ...

Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching among patients with psoriasis ...

An ustekinumab biosimilar to Stelara launched in France, completing its rollout across 5 major European markets and paving ...

Celltrion, a leading Korean biotechnology firm, has successfully developed Zymfentra, a subcutaneous version of the company’s ...

Stelara (ustekinumab) was launched almost 15 years ago as a treatment for psoriasis and in the interim has picked up additional indications in psoriatic arthritis, Crohn’s disease, and ...

Bimekizumab – an IL-17A and IL-17F inhibitor – outdid both placebo and IL-12/IL-23 blocker Stelara (ustekinumab ... additional data in psoriasis, psoriatic arthritis and ankylosing spondylitis ...

As Stelara biosimilars chip away at sales in Europe and off-brand rivals start to grace the stage in the U.S., Johnson & ...

Not only are pharmaceutical stocks excellent defensive investments in an uncertain economy, but some pharma stocks also pay ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...